Immuno-oncological treatments

Immuno-oncological treatments refer to cancer treatments (drugs) whose purpose is to strengthen the body's own immune response against cancer.

Previously used immunomodulators include interferon, used for the treatment of cancers such as melanoma. The new-generation immuno-oncological treatments are based on a different mechanism. They, too, were first used for the treatment of melanoma. Research data used as the basis for a marketing authorisation have so far been reported for melanoma, lung cancer and kidney cancer. In addition, preliminary research results have been reported, and more extensive studies on a number of other cancers are underway.

Currently, these new-generation immuno-oncological drugs include the CTLA-4 antibody ipilimumab, the PD-1 antibody pembrolizumab and the PD-1 antibody nivolumab. In addition, there are many therapies that are still being studied and have not yet been launched on the market. Oncolytic viruses constitute another group of immuno-oncological therapies. The first of these therapies to achieve a marketing authorisation is talimogene laherparepvec.

Docrates a forerunner in immuno-oncological treatments

Docrates Cancer Center started immuno-oncological treatments already in March 2015, using pembrolizumab. After this, we have also started nivolumab treatments. In addition, we have started or are about to start a number of drug trials with immuno-oncological treatments. You will find more information about our ongoing clinical trials here. Docrates has gained experience in oncolytic adenovirus research and treatments since 2007. Docrates was the first European centre with a certification for oncolytic herpes virus treatments.

Read more

Published: 07.06.2020

Why have our patients chosen Docrates Cancer Center?

There are as many reasons to choose a private cancer hospital as there are people. We compiled the reasons most...

Read more
Published: 07.06.2020

Cancer and Coronavirus – FAQ

The coronavirus is a concern among cancer patients. We listed the most common concerns and the answers to them.

Read more
Published: 07.06.2020

Your safety is the most important to us

Many cancer patients have several concerns when it comes to the coronavirus epidemic, e.g. how does the situation impact my...

Read more
Published: 07.06.2020

Many people want to go to work despite cancer, says Jorma Sormunen, new Oncologist at Docrates Cancer Center

In addition to oncology, Jorma Sormunen has years of experience in occupational healthcare. He has personally witnessed how important work...

Read more
Katso lisää

Why come to Docrates Cancer Center?

  • Top cancer experts and effective treatments without delay even during epidemic.
  • Individual care. You have your own care team - your doctor and your nurse.
  • Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
  • Experience in treating international patients from over 60 countries. Multilingual personnel.
358 10 773 2010

Contact us!

Mon-Thu 8 am-6 pm, Fri 8 am-4 pm (GMT +2)